1. MRI guided biopsy in patients with previously negative TRUS biopsy or suspicion of non-low grade disease on multiparametric MRI: High yield with predominantly intermediate to high risk prostate cancer found. (February 2017) Authors: Heijmink, S.; De Koekkoek-Doll, P.; Van der Poel, H.; Beets-Tan, R. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MRI-based periprostatic-fascia thickness measurements as tool to virtually predict postoperative erectile function after robot-assisted radical prostatectomy. (February 2017) Authors: Van der Roest, R.; KleinJan, G.; Heijmink, S.; Sikorska, K.; Tillier, C.; Schoots, I.; Buckle, T.; Van den Broek, B.; Jalink, K.; Van Leeuwen, F.; Van der Poel, H. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1182: PSMA-PET is superior to choline-PET based SABR for ADT deferral in oligometastatic prostate cancer. (November 2020) Authors: Deijen, C.; Vrijenhoek, G.; Vogel, W.; Moonen, L.; Pos, F.; Van der Poel, H.; Borst, G. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗